Streptococcus pneumoniae is the leading cause of bacterial pneumonia, acute otitis media and sinusitis and the most frequent aetiological agent of bacterial meningitis and bacteraemia. It is a major cause of morbidity and mortality among people all over the world (Maraki et al., 2001) . Virulence of S. pneumoniae is mainly associated with the presence of capsular polysaccharides, which usually exhibit differences in size, composition, antiphagocytic properties and serotypespecific immunogenicity. There are more than 90 pneumococcal serotypes, but less than a dozen are responsible for most of the infections (Ochoa et al., 2005) . Although penicillin has long been the mainstay of treatment of pneumococcal infections, the prevalence of penicillin resistance has been increasing worldwide. Penicillin resistance is usually associated with resistance to other antibiotics and poses a well-documented risk of therapeutic failure (Ochoa et al., 2005) .
The current study was conducted to determine the serotype distribution and antimicrobial susceptibility patterns of S. pneumoniae isolated from patients in Tunisia, in order to plan future treatment and preventive strategies.
Two hundred clinical isolates of S. pneumoniae collected from three university hospitals between 2000 and 2008 were analysed. Consecutive isolates (one per patient) were collected: 125 were invasive clinical isolates [pleural fluid (n577), cerebrospinal fluid (n529) and blood (n519)] and 75 were non-invasive isolates [ear (n534), sputum (n520), nose (n511) and eye (n510)]. Identification of S. pneumoniae species was based on conventional methods. Antimicrobial susceptibility testing was done by the disc diffusion method according to the Comité de l'Antibiogramme de la Société Française de Microbiologie (CA-SFM). MICs of penicillin, amoxicillin and cefotaxime were assessed by Etest according to the manufacturer's instructions (AB Biodisk) (CA-SFM). S. pneumoniae ATCC 49619 was used as a control strain. A multiplex PCR scheme was conducted to identify the most predominant serotypes (1, 3, 4, 6A/B, 7F, 7C, 8, 9A/V, 10A, 11A, 12F, 14, 15A, 15B/C, 16F, 17F, 18, 19A, 19F, 20, 22F, 23F, 31, 33, 34, 35B, 35F and 38) (Pai et al., 2006) . The x 2 and Fisher's exact tests were used for analysing the qualitative variables. All data were analysed with Epi Info software (version 6.0). A P-value of ,0.05 was considered statistically significant.
In the present study, as previously reported Reports from other countries showed that PRP or PIP isolates also carry genetic determinants encoding resistance to multiple antibiotics (Nowosiad & GiedrysKalemba, 2008) . In agreement with recent reviews, aminoglycosides, pristinamycin, rifampicin and vancomycin had excellent in vitro activity against all our strains (Maraki et al., 2001; Smaoui et al., 2009) . These drugs may be important alternatives for use in the treatment of infections caused by multidrug-resistant S. pneumoniae (Maraki et al., 2001) .
The most prevalent serotypes were in decreasing order 19F (17 %), 19A (11 %), 14 (11 %), 23F (9.5 %), 6B (9 %) and 6A (5.5 %). These serotypes accounted for 63 % of all isolates. Our results were similar to those recorded in several studies performed in different countries, Germany (Reinert et al., 2001) , Egypt (Wasfy et al., 2005) *CNS, Cefotaxime non-susceptible. DMultidrug resistance was defined as resistance to penicillin and to two or more classes of antimicrobial agents.
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